Prospective Clinical Study of R-CMD Therapy for Indolent B Cell Lymphoma and Mantle Cell Lymphoma From the Hokuriku Hematology Oncology Study Group

Medical Oncology - United States
doi 10.1007/s12032-015-0677-9